Cargando…

DNA methylation-based lung adenocarcinoma subtypes can predict prognosis, recurrence, and immunotherapeutic implications

The marked heterogeneity of lung adenocarcinoma (LUAD) makes its diagnosis and treatment difficult. In addition, the aberrant DNA methylation profile contributes to tumor heterogeneity and alters the immune response. We used DNA methylation array data from publicly available databases to establish a...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Feng, He, Lulu, Zhan, Xueqin, Chen, Jiexin, Xu, Huan, Huang, Xiaoling, Li, Yangyi, Zheng, Xiaohe, Lin, Ling, Chen, Yongsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803536/
https://www.ncbi.nlm.nih.gov/pubmed/33234739
http://dx.doi.org/10.18632/aging.104129